Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
暂无分享,去创建一个
T. Ogata | K. Tachibana | Y. Shishiba | Toshiaki Tanaka | Y. Naiki | Y. Hasegawa | S. Minowada | T. Hasegawa | R. Horikawa | N. Katsumata | D. Hasegawa | K. Nagasaki | M. Kagami | T. Yasuda | M. Yokozawa | N. Hori | N. Sato | S. Kawakita | Aki Shimotsuka